「ca」の検索結果
159件：46～50件目を表示
-
Company Profile | About Senju | SENJU Pharmaceutical
Corporate Name Senju Pharmaceutical Co.,Ltd. Headquarter 3-1-9, Kawara-machi, Chuo-ku, Osaka 541-0048,Japan TEL：+81-6-6201-2512 FAX：+81-6-6226-0406 Date of Incorporation April 9, 1947 Capital 1,415,50...
http://www.senju.co.jp/english/about/outline.html -
お知らせ | 千寿製薬株式会社
hthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） September 4, 2025 Senju has developed and obtain...
http://www.senju.co.jp/english/news/ -
Publications | Research & Development | SENJU Pharmaceutica
With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical Co., Ltd, Hyogo, Japan. 2: Baylor College of Medicine, Houston, Texas, USA American Journal of O...
http://www.senju.co.jp/english/rd/thesis/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
松和則 See more Overseas ARVO 2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dend...
http://www.senju.co.jp/english/rd/society/ -
Product Development Policy | Research & Development | SENJU Pharmaceutica
nagement philosophy of “Good Company” and a company that shapes “Beyond eyesight,” Senju Pharmaceutical has developed products that contribute to maintenance and improvement of “a joy to behold” or QO...
http://www.senju.co.jp/english/rd/policy/